Results 71 to 80 of about 5,730 (195)
Mean intravenous and IT-L serum I2S concentration-time profiles.
Error bars represent standard deviation.I2S, iduronate-2-sulfatase; IT-L, intrathecal lumbar; IV, intravenous.
Hongsheng Xie (716868) +3 more
core +1 more source
Mucopolysaccharidosis Type Ⅱ, as Known as Hunter syndrome, is a rare X-liked genetic disease caused by mutations in iduronate-2-sulfatase (IDS) gene.
Nayeon Lee, Haneul Noh, Chong Kun Cheon
doaj +1 more source
Aβ‐ and tau‐associated neuroinflammatory signatures in Alzheimer's disease
Abstract INTRODUCTION Neuroinflammation is increasingly recognized as a key contributor to Alzheimer's disease (AD) progression, with distinct responses linked to amyloid beta (Aβ) and tau pathology. Two detrimental waves of neuroinflammation have been proposed, the first during early Aβ accumulation, and the second during widespread tau deposition ...
Bruna Bellaver +23 more
wiley +1 more source
CM, cisterna magna; CSF, cerebrospinal fluid; I2S, iduronate-2-sulfatase; IT-L, intrathecal-lumbar.
Bob Crooker (3232881) +4 more
core +1 more source
Comparison of I2S concentrations in the white matter and the CSF after IT-L administration.
CM, cisterna magna; CSF, cerebrospinal fluid; ELISA, enzyme linked immunosorbent assay; I2S, iduronate-2-sulfatase; IT-L, intrathecal-lumbar.
Bob Crooker (3232881) +4 more
core +1 more source
Hunter Syndrome Diagnosed by Otorhinolaryngologist
Hunter syndrome is a lysosomal disease characterized by deficiency of the lysosomal enzyme iduronate-2-sulfatase (I2S). It has an estimated incidence of approximately 1 in 1,62,000 live male births.
Ayako Hashimoto +2 more
doaj +1 more source
Mucopolysaccharidosis type II (MPS II, Hunter syndrome) is X-linked recessive lysosomal storage disorder resulting from the defective activity of the enzyme iduronate-2-sulfatase (IDS).
Chkioua Latifa +8 more
doaj +1 more source
Detailed pedigree analyses and prenatal diagnosis for a family with mucopolysaccharidosis type II
Background Mucopolysaccharidosis type II (MPS II) is an X-linked multisystem disorder caused by mutations in the gene encoding iduronate 2-sulfatase (IDS).
Chuan Zhang +13 more
doaj +1 more source
Therapeutic potential of stem cells in pediatric neurology: Insights from clinical trials
Key characteristics of stem cells. Stem cells are essential in therapy due to their ability to self‐renew, ensuring a continuous supply of cells. They can derive from various sources, primarily embryonic tissue, and adult organs such as bone marrow and adipose tissue.
Daniel Bou Najm, Saada Alame
wiley +1 more source
Mean serum and CSF I2S concentration-time profiles with 0.5 mg/kg idursulfase intravenous dose.
Error bars represent standard deviation.CM, cisterna magna; CSF, cerebrospinal fluid; I2S, iduronate-2-sulfatase; IT-L, intrathecal lumbar.
Hongsheng Xie (716868) +3 more
core +1 more source

